Skip to content

Effects of Motion Sickness Patch on Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial

Effects of Motion Sickness Patch on Postoperative Nausea and Vomiting in Female Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600123207
Enrollment
Unknown
Registered
2026-04-22
Start date
2025-12-17
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

laparoscopic gallbladder surgery

Interventions

Anti-motion Patch Group (Group M) :In Group M, one anti-motion patch was applied behind both ears and at Yifeng acupoint 10 min before anesthesia induction, and maintained for 24 hours until the first
Control Group (Group C):In Group C, placebo patches of the same size without active ingredients were applied behind both ears and at Yifeng acupoint 10 minutes before anesthesia induction, and maintai

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female patients scheduled for elective laparoscopic cholecystectomy, classified as ASA physical status I-II. 2. History of motion sickness. 3. Non-smoker. 4. Aged between 18 and 65 years. 5. Body Mass Index (BMI) between 18 and 30 kg/m². 6. Able to communicate normally. 7. Voluntarily participate in the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergies to chrysanthemum, ginger, lemon, honeysuckle, mint, or binders; 2. Administration of antiemetics or analgesics within 24 hours prior to surgery; 3. Use of antipsychotic medications or corticosteroids; 4. A history of heart failure or cardiac arrhythmia; uncontrolled hypertension; poorly controlled diabetes mellitus; hepatorenal dysfunction; gastric motor disorder; or vestibular disease; 5. Pregnant or lactating females; 6. Inability to understand the Postoperative Quality of Recovery Scale (QoR-15) or Visual Analogue Scale (VAS).

Design outcomes

Primary

MeasureTime frame
Incidence of nausea and vomiting 24 hours after surgery;

Secondary

MeasureTime frame
PONV impact scale;Quality of recovery-15 items;PACU residence time; Use of remedial antiemetics and remedial analgesics;

Countries

China

Contacts

Public ContactLu Yao; Wu Min

Department of Anesthesiology, The First Affiliated Hospital of Anhui Medical University

xf2259@126.com+86 138 5697 0338

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026